Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene

Research output: Contribution to journalArticlepeer-review

Abstract

The human iPSC lines LEIi010-A and LEIi010-B were generated from the dermal fibroblasts of a patient with Usher syndrome using episomal plasmids containing OCT4, SOX2, KLF4, L-MYC, LIN28, mir302/367 microRNA and shRNA for p53. These iPSC lines carry compound heterozygous mutations (c.949C > A and c.1256G > T) in USH2A. LEIi010-A and LEIi010-B expressed pluripotent stem cell markers, had a normal karyotype and could be differentiated into endoderm, mesoderm and ectodermal lineages.

Original languageEnglish
Article number101420
Number of pages5
JournalStem Cell Research
Volume36
DOIs
Publication statusPublished - 1 Apr 2019

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Generation of two induced pluripotent stem cell lines from a patient with compound heterozygous mutations in the USH2A gene'. Together they form a unique fingerprint.

Cite this